research Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.
Search
for
Sort by
Research
690-720 / 1000+ results
research FEATURES OF THE DEVELOPMENT OF ACUTE DIFFUSE TELOGEN EFFLUVIUM IN PATIENTS WITH POST-COVID SYNDROME
Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.
research P62: An increase in Breslow thickness: coronavirus or coincidence?
The pandemic likely caused delays in skin cancer assessments, leading to fewer early diagnoses and thicker melanomas.
research The Profiles and The Characteristics of Post-COVID-19 Patients with Hair Loss and its Correlation with Trichoscopic Features, Vitamin D Levels, and Quality of Life
Post-COVID-19 hair loss is not linked to vitamin D or quality of life but is linked to hair graying.
research Dermatologic implications of COVID-19 infection and immunization: hair loss
Early treatment of COVID-19-related hair loss is crucial for better outcomes.
research ODP408 Elevated DHEAS and Acute Hair Loss in an Adult Male with Trichorhinophalangeal Syndrome Type 1: a Case of Male PCOS
A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.
research What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.
research Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.
research A Rare Case of Cronkhite-Canada Syndrome
Early diagnosis and nutritional support are crucial for managing Cronkhite-Canada Syndrome.
research Impact of the new corona virus (SARS-CoV-2) pandemic on climateric women’s health: websurvey
The pandemic worsened mental health and healthcare access for middle-aged women, leading to negative changes in their lifestyle.
research Prevalence of Telogen Effluvium in Egyptian Women with Post-Covid 19 Viral Infection
Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.
research Effects of pair housing on behavior, cortisol, and clinical outcomes during quarantine‐like procedures for rhesus macaques (Macaca mulatta)
Pair housing reduces stress behaviors and health issues in quarantined rhesus macaques.
research Decision‐Making Regarding the Administration of Live Vaccines to Patients With a FOXN1 Heterozygous Missense Variant
Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.
research Androgenetic alopecia in women and men is not related to COVID‐19 infection severity: a prospective cohort study of hospitalized COVID‐19 patients
Hair loss doesn't affect COVID-19 severity.
research Deficient anterior pituitary with common variable immune deficiency (DAVID syndrome): a new case and literature reports
DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.
research COVID-19 infection is a major cause of acute telogen effluvium
COVID-19 infection can significantly cause temporary hair loss.
research Greater susceptibility to telogen effluvium in the setting of severe COVID-19 infection: findings from a retrospective cohort study
Severe COVID-19 increases the risk of hair loss.
research The Effects of Changing Lifestyle and Daily Behaviours in the First Months of COVID-19 Outbreak on Dermatological Diseases: Retrospective Cross-Sectional Observational Study
Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.
research Medicine Update
The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.
research Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2
Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.
research A Systematic Scoping Review and Conceptual Analysis of New-Onset Fibromyalgia Manifestations After Non-Hospitalized COVID-19: Empirics, Definitions, Methodologies, Pathophysiology, Mapping of Literature, and Knowledge Gaps
New-onset fibromyalgia after COVID-19 is poorly understood, needing better definitions and studies.
research CECHY KLINICZNE PRZEBIEGU CHORÓB UKŁADU ODDECHOWEGO WYWOŁANYCH PRZEZ SARS-COV-2 U DZIECI Z ZACHODNICH REGIONÓW BIAŁORUSI
Urban children in western Belarus had more severe COVID-19 cases in 2021.
research A novel pathogenic variant of NECTIN4 gene in a child with ectodermal dysplasia-syndactyly syndrome
A child with ectodermal dysplasia-syndactyly syndrome has a new mutation in the NECTIN4 gene.
research The prognostic value of androgenetic alopecia and benign prostatic hyperplasia in men with COVID-19: a prospective multidisciplinaryobservational study of 766 patients from Turkey
Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.
research 14 viviendas unifamiliares adosadas: Urbanización Lares. Avda. Burgos. Logroño
COVID-19 can cause hair loss a few months after infection.
research Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.
research Dermatological Manifestations of COVID-19 in Children
COVID-19 can cause skin problems in children.
research Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.
research Cronkhite–Canada syndrome: from clinical features to treatment
There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.
research Research progress of post-acute sequelae after SARS-CoV-2 infection
Long COVID causes various long-term health issues and needs better awareness and treatment.